Fundraising September 15, 2024 – October 1, 2024 About fundraising

RVX-297, a BET bromodomain inhibitor, has therapeutic...

  • Main
  • 2017 / 09
  • RVX-297, a BET bromodomain inhibitor, has therapeutic...

RVX-297, a BET bromodomain inhibitor, has therapeutic effects in preclinical models of acute inflammation and autoimmune disease

Jahagirdar, Ravi, Attwell, Sarah, Marusic, Suzana, Bendele, Alison, Shenoy, Narmada, McLure, Kevin G, Gilham, Dean, Norek, Karen, Hansen, Henrik C, Yu, Raymond, Tobin, Jennifer, Wagner, Gregory S, You
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Molecular Pharmacology
DOI:
10.1124/mol.117.110379
Date:
September, 2017
File:
PDF, 1.28 MB
english, 2017
Conversion to is in progress
Conversion to is failed